GI Dynamics - Defining Noninvasive Metabolic Control

Press Releases

  • Study Demonstrates People Living with Type 2 Diabetes and Obesity Can Be Successfully Treated with GI Dynamics' EndoBarrierTM Gastrointestinal Liner for 12 Months

  • GI Dynamics' EndoBarrierTM Gastrointestinal Liner to be Highlighted
    at Upcoming Cleveland Clinic Conference

  • GI Dynamics Receives Strategic Investment from Medtronic, Inc.

  • GI Dynamics Receives European CE Mark Approval for the EndoBarrierTM Gastrointestinal Liner System for the Treatment of Type 2 Diabetes and Obesity

  • Interim Data from a Clinical Trial Evaluating GI Dynamics' EndoBarrierTM Gastrointestinal Liner in Patients with Type 2 Diabetes Presented at GASTRO 2009

  • GI Dynamics' EndoBarrierTM Gastrointestinal Liner Demonstrates Significant HbA1c Reduction in Obese People Living with Type 2 Diabetes

  • GI Dynamics' EndoBarrier™ Gastrointestinal Liner Demonstrates Safety and Efficacy in Pre-surgical Weight Loss

  • Data from a Clinical Study Evaluating GI Dynamics’ EndoBarrier to be Presented at IFSO

  • Novel Non-Surgical Therapy Dramatically Increases Weight Loss in Obese Patients; Results from Pilot Clinical Study Presented at ASMBS

  • GI Dynamics' EndoBarrier™ Gastrointestinal Liner to be Highlighted at Several Prominent International Diabetes and Obesity Meetings

  • GI Dynamics Closes an Additional $15 Million in Series C Financing

  • GI Dynamics Receives ISO Certification and European CE Mark Approval for the EndoBarrier™ Gastrointestinal Liner System

  • New Data in Journal Obesity Demonstrate that a Noninvasive, Removable Medical Device Results in Substantial Weight Loss and Glucose Normalization in a Preclinical Model of Obesity

  • GI Dynamics Announces Promising Multi-Center Safety and Efficacy Data of EndoBarrier™ Gastrointestinal Liner for Pre-Surgical Weight Loss

  • GI Dynamics Announces Data Demonstrating Immediate and Sustained Reduction in HbA1c in Patients with Type 2 Diabetes Using EndoBarrier™ Gastrointestinal Liner

  • Initial Results of GI Dynamics's EndoBarrier Presented at American Diabetes Association Conference